| |
| |
Good evening. This snapshot of stories and roundup is recommended just for you, based on your interests and reading history. | | | | (Washington Post illustration; Dr. Jonathan Tueting; KeriMedical) | | | | | | |  What to know A new thumb implant, the KeriMedical Touch CMC 1 Prosthesis, was approved by the FDA in 2025 and offers an alternative to trapeziectomy for treating thumb arthritis. It preserves thumb length, enhancing pinch and grip strength. Studies show faster recovery and improved function compared to traditional surgery. However, the implant requires replacement every 10-15 years and may not suit all patients. Summary is AI-generated, newsroom-reviewed. | | | | | How was today's newsletter? | | | | | | | | |
Have a question? Ask the Post AI to learn more 
